Clinical trial
Pharmaton Upgrade in Improving Mental Performance and Decreasing Fatigue
NCT00144235 · Boehringer Ingelheim, Industry · Completed
Key facts
| NCT number | NCT00144235 |
|---|---|
| Title | Pharmaton Upgrade in Improving Mental Performance and Decreasing Fatigue |
| Official title | A 28 Day, Randomised, Double-blind, Placebo-controlled, Single-centre Trial to Evaluate the Efficacy and Safety of Pharmaton® PHL 00749 Film Coated Tablets (G115 40 mg, Multivitamin, Multimineral + Guarana 75 mg) 1/Day p.o. in Improving Mental Performance and to Decrease Fatigue in Healthy Male and… |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Mental Competency, Mental Fatigue |
| Intervention type | Drug |
| Interventions | Pharmaton PHL 00749, Placebo |
| Enrollment | 412 |
| Start date | Mar 1, 2005 |
| Primary completion | Jul 1, 2005 |
| Completion | Jul 1, 2005 |
| First posted | Sep 5, 2005 |
| Last update posted | Oct 31, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: